Literature DB >> 4203467

Pharmacologic weakening of extraocular muscles.

A B Scott, A Rosenbaum, C C Collins.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4203467

Source DB:  PubMed          Journal:  Invest Ophthalmol        ISSN： 0020-9988


× No keyword cloud information.
  82 in total

1.  Botulinum toxin treatment of "one and a half syndrome".

Authors:  A Kipioti; R H Taylor
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

Review 2.  Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use.

Authors:  P Hambleton
Journal:  J Neurol       Date:  1992-01       Impact factor: 4.849

3.  [Pharmacology of botulinum toxin drugs].

Authors:  D Dressler
Journal:  HNO       Date:  2012-06       Impact factor: 1.284

4.  Ultrastructural changes in myotendinous nerve endings induced by injection of botulinum toxin into the extraocular muscle.

Authors:  Young-Woo Suh; Chang-Sub Uhm; Yoonae A Cho
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09-17       Impact factor: 3.117

Review 5.  Use of botulinum toxin in the neurology clinic.

Authors:  Erle C H Lim; Raymond C S Seet
Journal:  Nat Rev Neurol       Date:  2010-10-12       Impact factor: 42.937

6.  Botulinum toxin treatment of acute sixth and third nerve palsy.

Authors:  H S Metz; M Mazow
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

Review 7.  [Pharmacological aspects of therapeutic botulinum toxin preparations].

Authors:  D Dressler
Journal:  Nervenarzt       Date:  2006-08       Impact factor: 1.214

8.  Acute and long-term effects of botulinum neurotoxin on the function and structure of developing extraocular muscles.

Authors:  Scott A Croes; Larisa M Baryshnikova; Soniya S Kaluskar; Christopher S von Bartheld
Journal:  Neurobiol Dis       Date:  2007-01-10       Impact factor: 5.996

9.  Botulinum toxin infiltration for pain control after mastectomy and expander reconstruction.

Authors:  Rakhshanda Layeeque; Julio Hochberg; Eric Siegel; Kelly Kunkel; Julie Kepple; Ronda S Henry-Tillman; Melinda Dunlap; John Seibert; V Suzanne Klimberg
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

10.  [Botulinum toxin injection-treatment of upper lid retraction in thyroid eye disease].

Authors:  T Dintelmann; J Sold; F Grehn
Journal:  Ophthalmologe       Date:  2005-03       Impact factor: 1.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.